NON MEDICAL SWITCH FROM ETANERCEPT ORIGINATOR TO BIOSIMILAR GP2015 IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHROPATHIES

被引：0
|
作者：
Colaci, M. [1 ]
Aprile, M. L. [1 ]
La Rosa, A. [2 ]
Di Maggio, A. [2 ]
Malatino, L. [1 ]
机构：
[1] Univ Catania, Rheumatol Ctr, Osped Cannizzaro Clin & Expt Med, Catania, Italy
[2] Osped Cannizzaro, Serv Farm Osped, Catania, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.1557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0218
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [1] Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis
    Stefano Piaserico
    Andrea Conti
    Francesco Messina
    Alberto Meneguzzo
    Giulia Odorici
    Francesco Bellinato
    Paolo Gisondi
    [J]. BioDrugs, 2021, 35 : 469 - 471
  • [2] Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis
    Piaserico, Stefano
    Conti, Andrea
    Messina, Francesco
    Meneguzzo, Alberto
    Odorici, Giulia
    Bellinato, Francesco
    Gisondi, Paolo
    [J]. BIODRUGS, 2021, 35 (04) : 469 - 471
  • [3] GP2015: An Etanercept Biosimilar
    Emma D. Deeks
    [J]. BioDrugs, 2017, 31 : 555 - 558
  • [4] GP2015: An Etanercept Biosimilar
    Deeks, Emma D.
    [J]. BIODRUGS, 2017, 31 (06) : 555 - 558
  • [5] Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel®)
    Hofmann, Hans-Peter
    Kronthaler, Ulrich
    Fritsch, Cornelius
    Grau, Roger
    Mueller, Stefan O.
    Mayer, Robert
    Seidl, Andreas
    Da Silva, Antonio
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1185 - 1195
  • [6] Correction to: GP2015: An Etanercept Biosimilar
    Emma D. Deeks
    [J]. BioDrugs, 2018, 32 (5) : 525 - 525
  • [7] NON MEDICAL SWITCH FROM ADALIMUMAB ORIGINATOR TO THE BIOSIMILAR GP2017 IN PATIENTS AFFECTED BY CHRONIC ARTHRITIS
    Colaci, M.
    Aprile, M. L.
    La Rosa, A.
    Di Maggio, A.
    Malatino, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1135 - 1135
  • [8] Switching treatments of etanercept biosimilar GP2015 with originator product does not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis
    Griffiths, C. E.
    Reich, K.
    D, Thac, I
    Gerdes, S.
    Arenberger, P.
    Kingo, K.
    Weglowska, J.
    Woehling, H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S193 - S193
  • [9] Etanercept Biosimilar GP2015 Has Equivalent Efficacy and Safety to Etanercept Originator in Patients with Moderate to Severe Rheumatoid Arthritis: The Phase 3 Equira Study
    Kavanaugh, Arthur
    Allanore, Yannick
    Kucharz, Eugeniusz J.
    Babic, Goran
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] GP2015: An Etanercept Biosimilar (vol 31, pg 555, 2018)
    Deeks, Emma D.
    [J]. BIODRUGS, 2018, 32 (05) : 525 - 525
12345